SCHEMBL28512965

SCHEMBL28512965

Cn1c(=O)[nH]c2ncc(C#C[Si](C)(C)C)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
LMNA P02545 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
MEN1 O00255 1/20 0.38
PABPC1 P11940 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
PDE2A O00408 2/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
CYP3A4 P08684 2/20 0.35
PMP22 Q01453 2/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529536 0.81 CYP1A2 (0.63) CYP1A2LMNAADORA2AADORA2BMEN1
SCHEMBL28521892 0.74 TYRO3 (0.34) CYP1A2ALDH1A1KDM4EGAAPDE3B
SCHEMBL17813483 0.73 LMNA (0.45) CYP1A2LMNAADORA2AADORA2BMEN1
SCHEMBL22836260 0.72 LMNA (0.44) CYP1A2LMNAADORA2AADORA2BMEN1
SCHEMBL28522267 0.71 PDE3B (0.41) LMNAADORA2AADORA2BMEN1PABPC1
SCHEMBL25950360 0.70 ADORA2B (0.41) CYP1A2LMNAADORA2AADORA2BMEN1
SCHEMBL29795155 0.66 LMNA (0.46) LMNAADORA2AADORA2BMEN1PABPC1
SCHEMBL979460 0.66 LMNA (0.46) LMNAADORA2AADORA2BMEN1PABPC1
SCHEMBL977863 0.65 CYP1A2 (0.75) CYP1A2MTOR
SCHEMBL18850911 0.64 LMNA (0.49) LMNAADORA2AADORA2BMEN1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473476-B Alkynyl heterocyclic compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2021-02-19 CN disclosed